Sudeep Pharma remains in a strong Stage 2 uptrend, trading within a rising channel after its IPO base breakout. Price is currently consolidating, allowing the 50 DMA to catch up, while continuing to trade above all key moving averages.
Another positive sign is that volume has been drying up during the consolidation, suggesting selling pressure is fading. The large bearish candle on 6 Jul 2026 failed to receive downside follow-through, indicating sellers have not gained control. Meanwhile, the Nifty Pharma Index is trading near all-time highs, providing a supportive sector backdrop.
Trade Scenarios
Bullish: A breakout above the current base with strong volume could signal continuation of the Stage 2 uptrend.
Support Bounce: A pullback towards the lower boundary of the rising channel followed by a bullish reversal may offer another low-risk entry.
Bearish: A decisive breakdown below the current base, followed by a break below the 50 DMA and the lower boundary of the rising channel, would invalidate the current bullish structure and increase the probability of a deeper correction.
Markets remain sensitive to geopolitics, crude oil, and macroeconomic developments. Wait for price and volume confirmation—don't anticipate the move.
Disclaimer:
This analysis is shared for educational purposes only and reflects my personal study of the charts. I am not a SEBI-registered investment advisor. Nothing in this post should be construed as investment advice or a recommendation to buy or sell any security.
Study the chart carefully, build your own conviction, and never trade blindly. Risk management and proper position sizing are imperative—capital preservation always comes first.
Trade active
Update: The stock has delivered a strong move from the original analysis and is now showing a near-parabolic advance. From a technical perspective, this is no longer the type of low-risk entry discussed in the original idea. At this stage, it is better to let the chart develop and wait for a fresh base or another high-probability setup rather than chasing an extended move. Price action and volume over the coming sessions will provide further clues.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.